Xingli Zhou

839 total citations
28 papers, 570 citations indexed

About

Xingli Zhou is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Xingli Zhou has authored 28 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 8 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Xingli Zhou's work include Autoimmune Bullous Skin Diseases (9 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers) and Advancements in Transdermal Drug Delivery (4 papers). Xingli Zhou is often cited by papers focused on Autoimmune Bullous Skin Diseases (9 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers) and Advancements in Transdermal Drug Delivery (4 papers). Xingli Zhou collaborates with scholars based in China, Australia and United Kingdom. Xingli Zhou's co-authors include Wei Li, Ying Hao, Zhiyong Qian, Fan Yang, Liping Yuan, Hongjie Liu, Sushmita Pradhan, Wei Li, Yuting Song and Jesse Li‐Ling and has published in prestigious journals such as Frontiers in Immunology, Composites Part B Engineering and International Journal of Biological Macromolecules.

In The Last Decade

Xingli Zhou

25 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingli Zhou China 10 310 168 113 80 74 28 570
Xuan Jin China 8 401 1.3× 200 1.2× 108 1.0× 78 1.0× 43 0.6× 11 531
Antonio José Guillot Spain 11 370 1.2× 192 1.1× 109 1.0× 82 1.0× 61 0.8× 26 566
Basant Malik India 11 349 1.1× 77 0.5× 168 1.5× 88 1.1× 191 2.6× 15 664
Miriam López-Cervantes Mexico 8 308 1.0× 113 0.7× 64 0.6× 91 1.1× 100 1.4× 9 603
Barbara Weiß Germany 6 415 1.3× 295 1.8× 91 0.8× 82 1.0× 104 1.4× 11 672
Daya D. Verma United States 9 327 1.1× 192 1.1× 224 2.0× 51 0.6× 100 1.4× 11 634
Shuyao Ruan China 9 261 0.8× 138 0.8× 103 0.9× 92 1.1× 79 1.1× 10 451
Madeleine Witting Germany 8 209 0.7× 141 0.8× 168 1.5× 101 1.3× 136 1.8× 9 557
Keng Wooi Ng United Kingdom 14 241 0.8× 103 0.6× 231 2.0× 113 1.4× 64 0.9× 27 651
Anran Yuan China 13 260 0.8× 190 1.1× 188 1.7× 220 2.8× 96 1.3× 21 793

Countries citing papers authored by Xingli Zhou

Since Specialization
Citations

This map shows the geographic impact of Xingli Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingli Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingli Zhou more than expected).

Fields of papers citing papers by Xingli Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingli Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingli Zhou. The network helps show where Xingli Zhou may publish in the future.

Co-authorship network of co-authors of Xingli Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xingli Zhou. A scholar is included among the top collaborators of Xingli Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingli Zhou. Xingli Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Xun, Huaping Zheng, Xingli Zhou, et al.. (2025). Autoimmune bullous diseases: pathogenesis and clinical management. Molecular Biomedicine. 6(1). 30–30. 2 indexed citations
3.
Geng, Jia, et al.. (2024). A case of peeling skin syndrome type 1 with novel CDSN gene variation successfully treated with upadacitinib. The Journal of Dermatology. 52(3). 526–530.
4.
Xiao, Yue, et al.. (2024). Ofatumumab subcutaneous injection successfully treated patients with pemphigus vulgaris relapse post rituximab. The Journal of Dermatology. 51(7). 1026–1030. 3 indexed citations
5.
Liu, Pengcheng, Yuting Song, Longmei Zhao, et al.. (2024). Establishment and comparison of different procedures for modeling intrauterine adhesion in rats: A preliminary study. Heliyon. 10(3). e25365–e25365. 1 indexed citations
6.
Zhou, Xingli, et al.. (2024). Treatment with immunosuppressants did not increase the risk of COVID-19 in pemphigus patients: A single-center survey-based study. International Immunopharmacology. 135. 112307–112307. 2 indexed citations
7.
He, Xun, Jiwen Fan, Yongchao Yao, et al.. (2024). Advances in nanozymes with peroxidase-like activity for biosensing and disease therapy applications. Journal of Materials Chemistry B. 13(5). 1599–1618. 18 indexed citations
8.
Zhou, Xingli, et al.. (2024). The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study. Journal of Dermatological Treatment. 35(1). 2302071–2302071. 4 indexed citations
9.
Xiao, Yue, Yiyi Wang, Xingli Zhou, et al.. (2024). Eubacterium rectaleis a potential marker of altered gut microbiota in psoriasis and psoriatic arthritis. Microbiology Spectrum. 12(4). e0115423–e0115423. 12 indexed citations
10.
Nie, Rong, Qingyi Zhang, Jie Tan, et al.. (2023). EGCG modified small intestine submucosa promotes wound healing through immunomodulation. Composites Part B Engineering. 267. 111005–111005. 24 indexed citations
11.
Li, Mengmeng, Yiyi Wang, Xingli Zhou, et al.. (2023). Effects of ambient temperature on atopic dermatitis and attributable health burden: a 6-year time-series study in Chengdu, China. PeerJ. 11. e15209–e15209. 4 indexed citations
12.
Zhou, Xingli, Xun Feng, Hua Qian, et al.. (2023). Case Report: Prurigo nodularis-like linear IgA/IgG bullous dermatosis: a case report and literature review. Frontiers in Immunology. 14. 1201163–1201163. 2 indexed citations
13.
Zhang, Qingyi, Jie Tan, Rong Nie, et al.. (2023). Acceleration of wound healing by composite small intestinal submucosa hydrogels through immunomodulation. Composites Part B Engineering. 254. 110550–110550. 30 indexed citations
14.
Wang, Yiyi, Xingli Zhou, Yan Zhang, et al.. (2023). Association of gut microbiome and metabolites with onset and treatment response of patients with pemphigus vulgaris. Frontiers in Immunology. 14. 1114586–1114586. 12 indexed citations
15.
Li, Gaojie, Qin Zou, Yiyi Wang, et al.. (2022). Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study. Dermatology and Therapy. 12(9). 2105–2115. 5 indexed citations
16.
Li, Mengmeng, Hongmei Xiang, Yuxiang Liang, et al.. (2022). Secukinumab for PASS syndrome: A new choice for therapeutic challenge?. Dermatologic Therapy. 35(7). e15507–e15507. 8 indexed citations
17.
Zhou, Xingli, Liang Cheng, Yiyi Wang, et al.. (2021). Effect of NUDT15 polymorphisms on early hematological safety of low‐dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study. The Journal of Dermatology. 49(4). 402–410. 4 indexed citations
20.
Liang, Yuan, et al.. (2014). CCN1 enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia. Molecular Biology Reports. 41(9). 5813–5818. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026